Diagnosis and treatment of diabetic foot ulcer complicated with lower extremity vasculopathy: Consensus recommendation from the Chinese Medical Association (CMA), Chinese Medical Doctor Association (CMDA)
- PMID: 38402455
- DOI: 10.1002/dmrr.3776
Diagnosis and treatment of diabetic foot ulcer complicated with lower extremity vasculopathy: Consensus recommendation from the Chinese Medical Association (CMA), Chinese Medical Doctor Association (CMDA)
Abstract
Diabetic foot ulcer complicated with lower extremity vasculopathy is highly prevalent, slow healing and have a poor prognosis. The final progression leads to amputation, or may even be life-threatening, seriously affecting patients' quality of life. The treatment of lower extremity vasculopathy is the focus of clinical practice and is vital to improving the healing process of diabetic foot ulcers. Recently, a number of clinical trials on diabetic foot ulcers with lower extremity vasculopathy have been reported. A joint group of Chinese Medical Association (CMA) and Chinese Medical Doctor Association (CMDA) expert representatives reviewed and reached a consensus on the guidelines for the clinical diagnosis and treatment of this kind of disease. These guidelines are based on evidence from the literature and cover the pathogenesis of diabetic foot ulcers complicated with lower extremity vasculopathy and the application of new treatment approaches. These guidelines have been put forward to guide practitioners on the best approaches for screening, diagnosing and treating diabetic foot ulcers with lower extremity vasculopathy, with the aim of providing optimal, evidence-based management for medical personnel working with diabetic foot wound repair and treatment.
Keywords: bypass surgery; debridement; diabetic foot ulcer; endovascular therapy; lower extremity vasculopathy; microcirculation disturbance.
© 2024 The Authors. Diabetes/Metabolism Research and Reviews published by John Wiley & Sons Ltd.
Similar articles
-
[National expert consensus on the diagnosis and surgical treatment of diabetic foot ulcers complicated with lower extremity vasculopathy (2024 version)].Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2024 Mar 20;40(3):206-220. doi: 10.3760/cma.j.cn501225-20231122-00202. Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2024. PMID: 38548391 Free PMC article. Chinese.
-
Surgical amputation for patients with diabetic foot ulcers: A Chinese expert panel consensus treatment guide.Front Surg. 2022 Nov 8;9:1003339. doi: 10.3389/fsurg.2022.1003339. eCollection 2022. Front Surg. 2022. PMID: 36425891 Free PMC article.
-
Efficacy of Chinese and Western Medical Techniques in Treating Diabetic Foot Ulcers With Necrotizing Fasciitis of the Lower Leg.Int J Low Extrem Wounds. 2024 Mar;23(1):70-79. doi: 10.1177/15347346221150865. Epub 2023 Jan 17. Int J Low Extrem Wounds. 2024. PMID: 36648167
-
The value of debridement and Vacuum-Assisted Closure (V.A.C.) Therapy in diabetic foot ulcers.Diabetes Metab Res Rev. 2008 May-Jun;24 Suppl 1:S76-80. doi: 10.1002/dmrr.852. Diabetes Metab Res Rev. 2008. PMID: 18393328 Review.
-
Local wound care in diabetic foot complications. Aggressive risk management and ulcer treatment to avoid amputation.Postgrad Med. 1999 Jul;106(1):97-102. doi: 10.3810/pgm.1999.07.603. Postgrad Med. 1999. PMID: 10418578 Review.
Cited by
-
Diabetic foot in the context of rheumatic diseases: pathogenesis and treatment approaches.Rheumatol Int. 2025 May 2;45(5):132. doi: 10.1007/s00296-025-05890-8. Rheumatol Int. 2025. PMID: 40314825 Review.
-
Efficacy of tibial cortex transverse transport in treating diabetic foot ulcer and its effect on serum omentin-1 and irisin levels.Diabetol Metab Syndr. 2024 Jul 9;16(1):154. doi: 10.1186/s13098-024-01400-1. Diabetol Metab Syndr. 2024. PMID: 38982536 Free PMC article.
-
Probiotic active gel promotes diabetic wound healing through continuous local glucose consumption and antioxidant.J Nanobiotechnology. 2025 Jan 30;23(1):62. doi: 10.1186/s12951-025-03115-5. J Nanobiotechnology. 2025. PMID: 39885505 Free PMC article.
-
N4-acetylcytidine modification of LncRNA GFOD1-AS1 promotes high glucose-induced dysfunction in human dermal microvascular endothelial cells through stabilization of DNMT1 protein.Funct Integr Genomics. 2025 May 24;25(1):107. doi: 10.1007/s10142-025-01617-x. Funct Integr Genomics. 2025. PMID: 40411601 Free PMC article.
-
Assessment of extensor hallucis brevis stiffness and microcirculation in diabetes: shear wave elastography and contrast-enhanced ultrasound.Front Endocrinol (Lausanne). 2025 Jul 23;16:1639270. doi: 10.3389/fendo.2025.1639270. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40771279 Free PMC article.
References
REFERENCES
-
- Armstrong DG, Boulton A, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376(24):2367-2375. https://doi.org/10.1056/NEJMra1615439
-
- Zhang Y, Lazzarini PA, Mcphail SM, van Netten JJ, Armstrong DG, Pacella RE. Global disability burdens of diabetes-related lower-extremity complications in 1990 and 2016. Diabetes Care. 2020;43(5):964-974. https://doi.org/10.2337/dc19-1614
-
- Morbach S, Furchert H, Groblinghoff U, et al. Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a decade. Diabetes Care. 2012;35(10):2021-2027. https://doi.org/10.2337/dc12-0200
-
- Wagner FJ. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle. 1981;2(2):64-122. https://doi.org/10.1177/107110078100200202
-
- Lipsky BA, Senneville E, Abbas ZG, et al. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(Suppl 1):e3280. https://doi.org/10.1002/dmrr.3280
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical